Medicare Enrolled
Dr. Walter Coyle, M.D.
Gastroenterology · La Jolla, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Coyle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coyle?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Coyle
Dr. Walter Coyle is a gastroenterology specialist in La Jolla, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Coyle performed 1,179 Medicare services across 1,112 unique beneficiaries.
Between the years covered by Open Payments, Dr. Coyle received a total of $206,620 from 54 pharmaceutical and/or device companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Coyle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in CA
$206,620 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,179
Medicare services
Top 27% in CA for gastroenterology
1,112
Unique beneficiaries
$88
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
196 | $4 | $166 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $100 | $350 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
160 | $61 | $1,789 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
146 | $47 | $1,581 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
140 | $202 | $1,840 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $125 | $453 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
38 | $89 | $4,732 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $63 | $187 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $81 | $305 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
29 | $172 | $838 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $71 | $248 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $107 | $354 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
21 | $5 | $25 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
20 | $188 | $976 |
| Pancreatic or bile duct stent insertion A flexible endoscope is used to place a stent into the pancreatic or bile duct to keep it open. |
18 | $308 | $1,713 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
17 | $111 | $1,348 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
14 | $65 | $1,230 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
12 | $94 | $1,325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
47.9% medium
50.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$206,620
Total received (2018-2024)
Avg $29,517/year across 7 years
Top 2% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
596
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$196,368 (95.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,040 (3.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,212 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$66,372
2023
$60,574
2022
$13,433
2021
$26,801
2020
$345
2019
$15,388
2018
$23,706
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$51,363
ABBVIE INC.
$12,958
STERIS CORPORATION
$309
Boston Scientific Corporation
$266
GENZYME CORPORATION
$248
Takeda Pharmaceuticals U.S.A., Inc.
$184
PFIZER INC.
$175
Janssen Biotech, Inc.
$168
Merck Sharp & Dohme LLC
$144
Phathom Pharmaceuticals, Inc.
$144
Intercept Pharmaceuticals, Inc.
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
Merit Medical Systems Inc
$62
RedHill Biopharma Inc.
$54
ORPHALAN INC
$38
Ferring Pharmaceuticals Inc.
$36
AIMMUNE THERAPEUTICS, INC.
$35
EVOKE PHARMA, INC.
$23
VIVUS LLC
$22
Laborie Medical Technologies Corp.
$18
Top 3 companies account for 97.4% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$104,861
AbbVie Inc.
$32,003
AbbVie, Inc.
$25,966
ABBVIE INC.
$24,970
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$9,362
CSA Medical, Inc
$2,413
Takeda Pharmaceuticals U.S.A., Inc.
$1,104
PFIZER INC.
$864
Boston Scientific Corporation
$756
Janssen Biotech, Inc.
$624
GENZYME CORPORATION
$463
STERIS CORPORATION
$309
Ferring Pharmaceuticals Inc.
$298
Celgene Corporation
$259
Merck Sharp & Dohme LLC
$241
Olympus America Inc.
$232
UCB, Inc.
$177
Phathom Pharmaceuticals, Inc.
$144
Janssen Scientific Affairs, LLC
$125
Allergan Inc.
$111
Intercept Pharmaceuticals, Inc.
$106
INTERCEPT PHARMACEUTICALS, INC.
$103
VIVUS LLC
$82
Merck Sharp & Dohme Corporation
$80
Braintree Laboratories, Inc.
$76
RedHill Biopharma Inc.
$73
AIMMUNE THERAPEUTICS, INC.
$68
Merit Medical Systems Inc
$62
PENTAX of America, Inc.
$58
QOL Medical, LLC
$56
Blueprint Medicines Corporation
$53
NESTLE HEALTHCARE NUTRITION INC.
$48
Apollo Endosurgery US Inc
$41
ORPHALAN INC
$38
Ironwood Pharmaceuticals, Inc
$36
Shionogi Inc
$35
Daiichi Sankyo Inc.
$25
TAIHO ONCOLOGY, INC.
$23
Alexion Pharmaceuticals, Inc.
$23
EVOKE PHARMA, INC.
$23
Alnylam Pharmaceuticals Inc.
$20
Foundation Medicine, Inc.
$20
VIVUS, Inc.
$19
EISAI INC.
$19
Ardelyx, Inc.
$19
Laborie Medical Technologies Corp.
$18
Mallinckrodt Hospital Products Inc.
$18
Amgen Inc.
$18
Sun Pharmaceutical Industries Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
Alfasigma USA, Inc.
$15
Cook Medical LLC
$12
Dynavax Technologies Corporation
$12
INTRA-SANA LABORATORIES
$10
Top 3 companies account for 78.8% of all-time payments
Associated products mentioned in payments ›
6.0 X 26 CM WO/GW · AVSOLA · Abraxane · Acquire · Amitiza · Axios · C2 CryoBalloon · CAPTIVATOR COLD · CIMZIA · CLENPIQ · CREON · CUVRIOR · Cimzia · Cook Medical CBDE · Creon · DARZALEX · DIFICID · DUPIXENT · ENTYVIO · EOHILIA · EVIS EXERA III DUODENOVIDEOSCOPE · EndoMAXX Stent and Delivery System · Entyvio · FOUNDATIONONE · GATTEX · GENERAL ENDOCHOICE · GENERAL METAL STENTS GI · GENERAL - ENDOCHOICE · GENERAL HEMOSTASIS · GENERAL THERAPIES · GIMOTI · GIVLAARI · HUMIRA · Heplisav-B · Humira · IBSRELA · IMBRUVICA · INJECTAFER · KEYTRUDA · LIBTAYO · LINZESS · LONSURF · Lenvima · Linzess · MAVYRET · MOTOFEN · Mulpleta · OCALIVA · ODOMZO (sonidegib) capsules · ORCAPOD · Overstitch · PANCREAZE · PREPOPIK · PREVYMIS · QSYMIA · Qsymia · REBYOTA · RELTONE 200 MG · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUPREP · SUPREP BOWEL PREP · SUTAB · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · Talicia · TheraSphere Y90 Glass Microspheres 10 GBq · UCERIS · UROPASS II · Ultomiris · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · Vitrakvi · XELJANZ · XENON LAMP · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPOSIA · alpHaONE · truFreeze
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for gastroenterology in CA.
Geographic Context
Gastroenterologists within 10 mi
158
Per 100K population
4.8
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Coyle is a clinical cardiology specialist, with above-average Medicare volume (top 27% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Coyle experienced with moderate sedation during gi endoscopy?
Based on Medicare claims data, Dr. Coyle performed 196 moderate sedation during gi endoscopy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Coyle receive payments from pharmaceutical companies?
Yes. Dr. Coyle received a total of $206,620 from 54 companies across 596 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coyle's costs compare to other gastroenterologists in La Jolla?
Dr. Coyle's average Medicare payment per service is $88. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coyle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in La Jolla
Browse gastroenterologists in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology